RescueFlow will be approved in further EU countries
RescueFlow® will be approved in further EU countries BioPhausia today announces that RescueFlow®, based on the approval of the Swedish Medical Products Agency, will get marketing authorisations in Great Britain, Germany, France, The Netherlands, Denmark, Finland and Austria. The formal national registrations are expected within 1-3 months. It is later possible to apply in additional EU countries in a second wave of the registration procedure. Erika Kjellberg Eriksson, President, BioPhausia: " The approval of RescueFlow® for marketing in these significant countries is a great success. Our